Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yoshiaki, Matsuura"'
Autor:
Masako Yamamoto, MD, Yuriko Kawase, MD, PhD, Emi Nakajima, MD, PhD, Yoshiaki Matsuura, MD, PhD, Wataru Akita, MD, PhD, Ryousuke Aoki, MD, PhD, Yusuke Suzuki, MD, PhD, Hiroshi Mitsui, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 21, Iss , Pp 150-153 (2022)
Externí odkaz:
https://doaj.org/article/3568c01318554cd2a848dca2f412608f
Autor:
Yoshiaki Matsuura, Motohiro Nishimura, Kinya Furuichi, Rina Hirohashi, Satoshi Teramukai, Junichi Shimada, Masayoshi Inoue
Publikováno v:
General Thoracic and Cardiovascular Surgery. 70:1015-1021
Computed tomography (CT)-guided lipiodol marking is one of the targeting methods for resecting small pulmonary nodules or ground-glass nodules in video-assisted thoracic surgery (VATS). However, lipiodol spreading during marking has not been assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7336b04aae6d9c3dec7fa486b0ea2a1
https://doi.org/10.1007/s11748-022-01842-2
https://doi.org/10.1007/s11748-022-01842-2
Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney
Autor:
Fumiaki Ando, Tamami Fujiki, Takuya Fujimaru, Taisuke Furusho, Ayaka Usui, Tomoki Yanagi, Koichiro Susa, Makoto Arita, Hiroaki Kikuchi, Takayasu Mori, Kenichi Asano, Kouhei Yamamoto, Eisei Sohara, Naohiro Takahashi, Yoshiaki Matsuura, Tatemitsu Rai, Shinichi Uchida, Shintaro Mandai
Publikováno v:
Clinical and Experimental Nephrology. 25:445-455
Background Lipid-metabolizing enzymes and their metabolites affect inflammation and fibrosis, but their roles in chronic kidney disease (CKD) have not been completely understood. Methods To clarify their role in CKD, we measured the mRNA levels of ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93cc54d55aed57bbcc6c63b9dcf5d554
https://doi.org/10.1007/s10157-021-02021-y
https://doi.org/10.1007/s10157-021-02021-y
Autor:
Naohiro, Takahashi, Hiroaki, Kikuchi, Ayaka, Usui, Taisuke, Furusho, Takuya, Fujimaru, Tamami, Fujiki, Tomoki, Yanagi, Yoshiaki, Matsuura, Kenichi, Asano, Kouhei, Yamamoto, Fumiaki, Ando, Koichiro, Susa, Shintaro, Mandai, Takayasu, Mori, Tatemitsu, Rai, Shinichi, Uchida, Makoto, Arita, Eisei, Sohara
Publikováno v:
Clinical and Experimental Nephrology
Background Lipid-metabolizing enzymes and their metabolites affect inflammation and fibrosis, but their roles in chronic kidney disease (CKD) have not been completely understood. Methods To clarify their role in CKD, we measured the mRNA levels of ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b977b7176c47789b53228fc560a3b7a2
https://pubmed.ncbi.nlm.nih.gov/33595729
https://pubmed.ncbi.nlm.nih.gov/33595729
Autor:
Fumiaki Ando, Koichiro Susa, Tatemitsu Rai, Wakana Shoda, Yoshiaki Matsuura, Naohiro Nomura, Takayasu Mori, Shinichi Uchida, Kiyoshi Isobe, Eisei Sohara
Publikováno v:
Biochemical and biophysical research communications. 517(2)
Type 4 Bartter syndrome (BS) is caused by genetic mutations in barttin, which is coded for by BSND. Barttin serves as the β-subunit of the ClC-K chloride (Cl-) channel, which is widely expressed in distal nephrons. Type 4 BS is characterized by seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c77a3fe7498f4ecfa83d1c51ebacb74
https://pubmed.ncbi.nlm.nih.gov/31362893
https://pubmed.ncbi.nlm.nih.gov/31362893
Publikováno v:
Journal of Thoracic Oncology. 12:S867-S868
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fc4460126767d86e1bf64fd47c582ae
https://doi.org/10.1016/j.jtho.2016.11.1180
https://doi.org/10.1016/j.jtho.2016.11.1180
Autor:
Yoshiaki Matsuura
Publikováno v:
Japanese Journal of Administrative Science. 16:25-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f493d7b297db75089af6bef5f9de49c
https://doi.org/10.5651/jaas.16.25
https://doi.org/10.5651/jaas.16.25
Autor:
Takashi Kondo, Yoshiaki Matsuura, Mikiji Miyata, Kazunori Nakano, Kazuki Sada, Kunio Miki, Masahiko Ushioda
Publikováno v:
Bulletin of the Chemical Society of Japan. 71:1931-1937
Clathrate formation and crystal structures of 3α, 7α, 12α-trihydroxy-5β-cholan-24-amide (cholamide) have been investigated. Cholamide forms inclusion compounds with various organic compounds having hydrogen-bond (H-bond) donors. X-Ray crystallogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc1a1e31c572f362913c9e1e363aa5e9
https://doi.org/10.1246/bcsj.71.1931
https://doi.org/10.1246/bcsj.71.1931
Publikováno v:
Molecular Crystals and Liquid Crystals Science and Technology. Section A. Molecular Crystals and Liquid Crystals. 276:121-127
Crystal structure of an inclusion crystal of cholanamide with aniline is described. Comparison of the crystal structure with that of the cholic acid clathrate reveals both hosts have quite similar assembly mode. However, the most smking difference is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::863bb4f6f163297dfd0d10202aa537ce
https://doi.org/10.1080/10587259608039368
https://doi.org/10.1080/10587259608039368
Publikováno v:
ChemInform. 29
Hyodeoxycholic acid forms inclusion crystals with aromatic amines such as pyridine, aniline and toluidines. The crystal structure of a 1:1 inclusion compound of hyodeoxycholic acid with pyridine was determined.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88710873118beb1ff1ec8a6fcd5db7fe
https://doi.org/10.1002/chin.199816194
https://doi.org/10.1002/chin.199816194